General information
- Inherited hydrocephalus (HCP) with phenotypic expression in males, passed on through carrier mothers who are phenotypically normal.
- Classical phenotypic expression will skip single generations.
Numbers
- Incidence: 1/25,000 to 1/60,000.
- Prevalence: ≈ 2 cases per 100 cases of hydrocephalus.
Genetics
- X-linked pattern
- Mutations in the L1CAM gene (Xq28) encoding the L1 cell adhesion molecule that is expressed mainly in the developing nervous system.
- L1CAM membrane-bound receptor
- Function
- CNS development for axonal migration to appropriate target locations through Integrin cell adhesion molecules and MAP Kinase signal cascade.
Pathophysiology
- Abnormal gene expression results in poor differentiation and maturation of cortical neurons, macroscopic anatomical abnormalities.
- Mild L1 Syndrome
- Mutations retaining expression of some functional protein (component imbedded in cell membrane)
- Adducted thumbs, spastic paralysis, hypoplasia of CC
- Severe L1 syndrome
- Cytoplasmic domain loss of function mutations
- Symptoms of mild L1 syndrome
- Anterior cerebellar vermis hypoplasia
- Large massa intermedia, enlarged quadrigeminal plate, rippled ventricular wall following VP shunt placement (pathognomonic for X-linked HCP).
- Profound mental retardation in virtually all cases
L1 syndromes
- Classical syndromes
- CRASH
- Corpus callosum hypoplasia
- Retardation
- Adducted thumbs (clasp thumbs)
- Spastic paralysis
- HCP
- MASA
- Mental handicap
- Aphasia
- Shuffling gait
- Adducted thumbs
- HSAS
- HCP with Stenosis of the Aqueduct of Sylvius.
- Recent delineations
- Mild L1 syndrome
- Adducted thumbs, spastic paralysis, hypoplasia of CC
- Severe L1 syndrome
Radiographic findings
- (Esp for severe cases)
- Severe symmetric HCP with predominant posterior horn dilation
- Hypoplastic CC/ACC
- Hypoplastic anterior cerebellar vermis
- Large massa intermedia
- Large quadrigeminal plate
- Rippled ventricular wall following VP shunt placement (pathognomonic)
Treatment
- No intervention demonstrates improvement in retardation status in observational papers.
- VP shunt
- Main purpose is management of head size for improved care by caregiver.
- Does not improve neurologic outcome
- No genetic therapies for L1CAM protein abnormalities
- Prenatal U/S
- Early (≈ 20–24 weeks gestational age) with frequent repeat scan in known carrier mothers.
- May allow for medically indicated termination early on.
- Genetic testing for L1CAM mutation
- Male infants with HCP and≥ 2 clinical/radiographic signs